Patient Recruitment Company StudyKIK Announces Their In-House, GCP Certified Patient Qualification Department for Clinical Trial Patient Recruitment

Thursday, November 15, 2018 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

StudyKIK has created a department to contact patients and pre-screen them through highly trained and experienced staff members, just like the patients would experience with a clinical site coordinator.

COSTA MESA, Calif., Nov. 14, 2018 /PRNewswire-PRWeb/ -- StudyKIK, a patient recruitment company headquartered in

Costa Mesa, California, announces their fully-developed patient pre-screening service for research sites and pharmaceutical companies enrolling early and late phase clinical trials. This innovative patient recruitment company has been focused on patient referral quality since its inception, with a goal of cutting down on research site's workload when processing patient referrals. StudyKIK received feedback from many clinicians that a major pain-point in their workflow is having to speak with an extensive amount of patients who do not qualify for a clinical trial in order to find a few that do. This labor intensive-exercise hinders some sites from being able to enroll more qualified patients and further medical research. To help, StudyKIK created a department to contact patients and pre-screen them through highly trained and experienced staff members, just like the patients would experience with a clinical site coordinator.

Chris Caldron, Director of Patient Qualification at StudyKIK stated; "We are excited to offer a service to the clinical trial industry that allows StudyKIK to do the time-consuming task of getting a interested patient on the phone for a research site, conduct a thorough pre-qualification of the patient, then call the research site with the pre-qualified patient on the phone to live transfer the patient to the site."

Though this platform is designed to work into the operational workflow of a research site, StudyKIK has designed this service to be offered to CRO and Sponsor partners who need additional support for their upcoming or ongoing clinical programs. StudyKIK's "Patient Qualification Department" is also capable of providing study sponsors a complete analytical dashboard to manage and monitor all patient pre-screening going through StudyKIK's Patient Qualification Department.

StudyKIK's President Matt Miller Stated; "We wanted to provide an internal Patient Qualification Center focused on quality as we have heard from many sites that when their patient screening has been outsourced to other industry call centers, the patient screening quality has not been very high which creates a great deal of extra work on the site. Sites would then have to take up their time screening patients that do not qualify. StudyKIK's focus is on quality across all that we do and providing this internal pre-screening service to the industry, we can move away from large call centers that may not understand protocol design and how to talk to patient about their disease."

StudyKIK has made a large commitment in offering patient pre-screening through their own internal team with all data being completely integrated into all site and CRO/Sponsor portals. By continuously striving to be the most reliable and innovative patient recruitment provider in the industry, this new offering is another step toward StudyKIK's goal of helping patients and bringing new treatments to the marketplace as fast as possible.

More About StudyKIK: StudyKIK utilizes social media to provide disruptive patient recruiting solutions for clinical trial sites, clinical research organizations, and pharmaceutical companies. The Company is a first mover in the patient recruitment space, using social media to address recruiting and retention of patients in the $40bn+ clinical trial industry that has historically relied on traditional advertising mediums such as print and radio. StudyKIK serves over 1,600 research sites with a growing database of over 2,000,000 patients from its extensive social media communities across Facebook, Instagram, Snapchat, Twitter, and Pinterest.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store